Skip to content

AXSM AXSOME THERAPEUTICS INC.

Follow

Stock (common), issuer CIK 1579428

Filings received so far for Q3 2026: 7 13F filers report a position in AXSM shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Mirador Capital Partners LP4,000$738K0.09%013F-HRTimeline
ARMSTRONG ADVISORY GROUP, INC424$78.2K<0.01%+113F-HRTimeline
GAMMA Investing LLC416$76.7K<0.01%+6913F-HRTimeline
Farther Finance Advisors, LLC374$69K<0.01%-14113F-HRTimeline
Versant Capital Management, Inc215$39.6K<0.01%+513F-HRTimeline
MassMutual Private Wealth & Trust, FSB51$9.4K<0.01%-213F-HRTimeline
Marquette Asset Management, LLC4$738<0.01%013F-HRTimeline